Скачать или смотреть Model-Integrated Evidence for Generic Drug Development – Session 1C

Presenters and a panel discuss exploring opportunities and challenges for utilizing artificial intelligence (e.g., machine learning and natural language processing) to support generic drug development and application assessment. Presentation titles include, “Artificial Intelligence in Pharmaceutics,” and “Artificial Intelligence in Generic Drug Development – Experience and Opportunities,” and “Improving Generic Drugs and Streamlining Their Approval Through Artificial Intelligence.”
Learn more at: https://www.fda.gov/drugs/news-events...
_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Upcoming Training - https://www.fda.gov/cdersbia
SBIA Listserv - https://public.govdelivery.com/accoun...
SBIA 2021 Playlist -    • 2021 CDER Small Business and Industry Assi...  
SBIA LinkedIn:   / cder-small-business-and-industry-assistance  
SBIA Training Resources - https://www.fda.gov/cdersbialearn
Twitter -   / fda_drug_info  
Email - [email protected]  
Phone - (301) 796-6707 I (866) 405-5367